Rainbow Children’s Medicare Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 15, 2026
- Posted by: Harsh Piplani
- Category: Results
Rainbow Children’s Medicare share price Rs 1,432.00 on 15 September 2026, down 0.89%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 63.00 crore. Q2 FY26 base a profit of Rs 76.00 crore.
Quick Answer
The Rainbow Children’s Medicare Q2 results date for FY27 is not confirmed, and Rainbow Children’s Medicare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 15 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 445.00 crore in revenue and a profit of Rs 76.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Rainbow Children’s Medicare Q2 results FY27 announcement is the next scheduled earnings event for Rainbow Children’s Medicare Ltd., a paediatric hospital chain running about twenty four hospitals and five clinics across nine cities under the Rainbow Children’s Hospital and BirthRight brands, covering paediatrics, paediatric intensive care, neonatology, obstetrics, gynaecology and fertility. The stock traded at Rs 1,432.00 on the NSE on 15 September 2026, down 0.89% from the previous close of Rs 1,444.90, about 11.1% below its 52-week high of Rs 1,610.00 and 32.1% above its 52-week low of Rs 1,084.00.
What makes the Rainbow Children’s Medicare Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 445.00 crore of revenue and a profit of Rs 76.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 470.00 crore and a profit of Rs 63.00 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Rainbow Children’s Medicare Q2 Results FY27 Date?
The Rainbow Children’s Medicare Q2 results date for FY27 is not confirmed. As of 15 September 2026, Rainbow Children’s Medicare Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Rainbow Children’s Medicare Q2 results date becomes public through that filing rather than through any advance announcement.
The Rainbow Children’s Medicare Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Rainbow Children’s Medicare.
Rainbow Children’s Medicare Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Rainbow Children’s Medicare Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Rainbow Children’s Medicare. The Rainbow Children’s Medicare Q2 results watchlist below is built from what the company has actually reported and disclosed.
The first is revenue, which was Rs 445 crore in September 2025 against Rs 470 crore in Q1 FY27, a rise of about 6%. Sales have risen in every quarter of the window, from Rs 353 crore in June 2025, as beds were added.
The second is the operating margin, which was 33% in September 2025 and 29% in Q1 FY27. Operating profit has now fallen for four consecutive quarters, from Rs 149 crore to Rs 135 crore, while revenue rose in each of them, so cost is growing faster than the top line.
The third is the March 2026 base, which was flattered by tax. That quarter was charged at 10% against 24% to 26% in the other four, worth roughly Rs 13 crore, which is about a fifth of its Rs 78 crore and the reason its earnings per share of Rs 7.59 is the highest in the window.
Check Rainbow Children’s Medicare Ltd. Live Fundamentals on the Univest Screener
Rainbow Children’s Medicare Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Rainbow Children’s Medicare Ltd. reported revenue of Rs 470.00 crore in Q1 FY27, up 33.14% from Rs 353.00 crore in Q1 FY26, and a profit of Rs 63.00 crore at the net level, up 16.67% from Rs 54.00 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was up 2.17% over the March 2026 quarter figure of Rs 460.00 crore, and net profit was down 19.23% from Rs 78.00 crore in Q4 FY26. Operating margin stood at 29% in Q1 FY27 against 33% in the September 2025 quarter, which is the comparison the Rainbow Children’s Medicare Q2 results print will be read against.
Q2 FY26 Base: The Comparison Rainbow Children’s Medicare Q2 Results FY27 Must Beat
Rainbow Children’s Medicare Ltd. reported revenue of Rs 445.00 crore and a profit of Rs 76.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Rainbow Children’s Medicare Q2 results preview.
Net profit in that base quarter was above the Rs 63.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 445.00 crore sits below the Rs 470.00 crore of the June 2026 quarter, which frames how much sequential movement the Rainbow Children’s Medicare Q2 results print needs to show growth.
Rainbow Children’s Medicare Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 445.00 | 76.00 |
| Q3 FY26 (Dec 2025) | 445.00 | 74.00 |
| Q4 FY26 (Mar 2026) | 460.00 | 78.00 |
| Q1 FY27 (Jun 2026) | 470.00 | 63.00 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Rainbow Children’s Medicare Q2 results preview uses.
Revenue across those four quarters ranged from Rs 445.00 crore to Rs 470.00 crore, and net profit from Rs 63.00 crore to Rs 78.00 crore. That spread is the honest context for the Rainbow Children’s Medicare Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Rainbow Children’s Medicare Q2 Results FY27
The Rainbow Children’s Medicare Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Rainbow Children’s Medicare has already reported.
New Hospitals Cost Before They Earn
Interest rose from Rs 18 crore to Rs 21 crore and depreciation from Rs 34 crore to Rs 42 crore across the five quarters as capacity was added. A new unit carries its full lease, staff and depreciation cost well before occupancy matures, which is the most direct explanation for a falling operating profit on rising revenue.
Paediatric Demand Is Seasonal
Respiratory and infectious illness in children peaks around and after the monsoon, so the September quarter is usually a strong one for occupancy. September 2025 was the best margin quarter of the window at 33%.
The Rating Assumes the Expansion Works
A price to earnings ratio of 51.64 and a price to book ratio of 8.96 stand against return on equity of 15.9%. Borrowings against reserves give a debt to equity ratio of 0.54, most of which is the lease and facility funding behind the new units.
Rainbow Children’s Medicare Q2 Results FY27: Share Price and Valuation Going Into the Print
Rainbow Children’s Medicare share price today is Rs 1,432.00 on the NSE, down Rs 12.90 or 0.89% from the previous close of Rs 1,444.90 on 15 September 2026, ahead of the Rainbow Children’s Medicare Q2 results announcement.
| Metric | Value (15 September 2026) |
|---|---|
| NSE Symbol | RAINBOW |
| Current Market Price | Rs 1,432.00 |
| 52-Week High | Rs 1,610.00 |
| 52-Week Low | Rs 1,084.00 |
| Market Capitalisation | Rs 14,540 crore |
| PE Ratio | 50.96 |
| PB Ratio | 8.84 |
| EPS (TTM) | Rs 28.10 |
| Book Value per Share | Rs 162.00 |
| Debt to Equity | 0.54 |
| Return on Equity | 15.9% |
| 50-Day Moving Average | Rs 1476.96 |
| 200-Day Moving Average | Rs 1327.63 |
| RSI (14) | 46.28 |
The stock trades below its 50-day average of Rs 1476.96 but above its 200-day average of Rs 1327.63, with a 14-day RSI of 46.28. None of this is a view on where the shares go once the Rainbow Children’s Medicare Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Rainbow Children’s Medicare Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Rainbow Children’s Medicare Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Rainbow Children’s Medicare Q2 results print in proportion.
- Revenue against the Rs 445.00 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 76.00 crore in that same quarter
- Operating margin against 29% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Rainbow Children’s Medicare Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Rainbow Children’s Medicare Q2 Results FY27
The Rainbow Children’s Medicare Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Rainbow Children’s Medicare Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Rainbow Children’s Medicare Q2 results FY27 print faces a base of Rs 445.00 crore in revenue and a profit of Rs 76.00 crore, with the most recent quarter having delivered Rs 470.00 crore and a profit of Rs 63.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Rainbow Children’s Medicare, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Rainbow Children’s Medicare Q2 Results FY27
What is the Rainbow Children’s Medicare Q2 results date for FY27?
Ans. The Rainbow Children’s Medicare Q2 results date for FY27 is not confirmed. Rainbow Children’s Medicare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 15 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Rainbow Children’s Medicare Q2 results 2026 cover?
Ans. The Rainbow Children’s Medicare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Rainbow Children’s Medicare Ltd. reports revenue, operating profit and net profit for that period, and the Rainbow Children’s Medicare Q2 results filing also carries the notes to the accounts.
What were the Rainbow Children’s Medicare Q1 FY27 results?
Ans. Rainbow Children’s Medicare Ltd. reported revenue of Rs 470.00 crore in Q1 FY27 and a profit of Rs 63.00 crore at the net level. Revenue was up 33.14% versus Q1 FY26 and net profit was up 16.67% from Rs 54.00 crore in Q1 FY26.
What were Rainbow Children’s Medicare Q2 FY26 results in the September 2025 quarter?
Ans. Rainbow Children’s Medicare Ltd. reported revenue of Rs 445.00 crore and a profit of Rs 76.00 crore in Q2 FY26. Operating margin was 33%. Those figures form the base for the Rainbow Children’s Medicare Q2 results FY27 comparison.
What are the main Rainbow Children’s Medicare Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Rainbow Children’s Medicare Q2 results expectations centre on revenue against the Rs 445.00 crore base, net profit against a profit of Rs 76.00 crore, operating margin against 29% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Rainbow Children’s Medicare share price today ahead of the Q2 earnings?
Ans. Rainbow Children’s Medicare share price is Rs 1,432.00 on the NSE as of 15 September 2026, down 0.89% from Rs 1,444.90. The stock is about 11.1% below its 52-week high of Rs 1,610.00 and 32.1% above its 52-week low of Rs 1,084.00, at a market capitalisation of Rs 14,540 crore.
Is Rainbow Children’s Medicare a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Rainbow Children’s Medicare Ltd. The stock trades at a price-to-book ratio of 8.84 with a return on equity of 15.9%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
